Akeso’s Gumokimab Monoclonal Antibody (IL-17) New Drug Application for the Treatment of Moderate to Severe Psoriasis Accepted by NMPA By Investing.com Leonardo Martins 01/27/2025
Alphabet’s chief accounting officer sells $559,849 in stock By Investing.com Marcel Trisent 12/18/2024
